Menu

  • Home
Skip to content

John Barleycorn

All the news they won't print.

not for sale

Drug companies are sitting on generics—43% of recently approved aren’t for sale | Ars Technica

Posted on February 11, 2019 by johnbarleycorn12

You pay more for medicine because hundreds of generics aren’t for sale.
— Read on arstechnica.com/science/2019/02/drug-companies-are-sitting-on-generics-43-of-recently-approved-arent-for-sale/

Big pharma again.

Create a free website or blog at WordPress.com.
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Subscribe Subscribed
    • John Barleycorn
    • Join 770 other subscribers
    • Already have a WordPress.com account? Log in now.
    • John Barleycorn
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar